Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Total Debt (2016 - 2023)

Creative Medical Technology Holdings (CELZ) has disclosed Total Debt for 14 consecutive years, with $14194.0 as the latest value for Q1 2023.

  • On a quarterly basis, Total Debt changed 0.0% to $14194.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $14194.0, a 0.0% change, with the full-year FY2022 number at $14194.0, changed 0.0% from a year prior.
  • Total Debt was $14194.0 for Q1 2023 at Creative Medical Technology Holdings, roughly flat from $14194.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $6.8 million in Q4 2019 to a low of $10800.0 in Q1 2019.
  • A 5-year average of $936834.9 and a median of $22082.0 in 2020 define the central range for Total Debt.
  • Biggest YoY gain for Total Debt was 23457.04% in 2019; the steepest drop was 99.85% in 2019.
  • Creative Medical Technology Holdings' Total Debt stood at $6.8 million in 2019, then crashed by 99.57% to $29582.0 in 2020, then plummeted by 52.02% to $14194.0 in 2021, then changed by 0.0% to $14194.0 in 2022, then changed by 0.0% to $14194.0 in 2023.
  • Per Business Quant, the three most recent readings for CELZ's Total Debt are $14194.0 (Q1 2023), $14194.0 (Q4 2022), and $14194.0 (Q3 2022).